[Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
D000328:Adult; D000577:Amides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002037:Bundle-Branch Block / Q000188:drug therapy; D002082:Butylamines / Q000627:therapeutic use; D004048:Diethylamines / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006325:Heart Atria / Q000187:drug effects; D006327:Heart Block / Q000188:drug therapy; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009281:Naphthalenes / Q000627:therapeutic use*
D000577:Amides; D000889:Anti-Arrhythmia Agents; D002082:Butylamines; D004048:Diethylamines; D009281:Naphthalenes
Effetti di un nuovo farmaco antiaritmico, la bunaftine, sulla conduzione intra-atriale, atrio-ventricolare ed intraventricolare dello stimolo